Trial · NCT00385138
Results by group40
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 40
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Incidence of All-cause Mortality, Myocardial Infarction (MI), and Ischemia-driven Revascularization (IDR) | Cangrelor | 185 | participants | ||
| Incidence of All-cause Mortality, Myocardial Infarction (MI), and Ischemia-driven Revascularization (IDR) | Clopidogrel | 210 | participants | ||
| Incidence of All-cause Mortality or MI | Cangrelor | 180 | participants | ||
| Incidence of All-cause Mortality or MI | Clopidogrel | 204 | participants | ||
| Incidence of All-cause Mortality | Cangrelor | 6 | participants | ||
| Incidence of All-cause Mortality | Clopidogrel | 18 | participants | ||
| Incidence of MI | Cangrelor | 177 | participants | ||
| Incidence of MI | Clopidogrel | 191 | participants | ||
| Incidence of IDR | Cangrelor | 19 | participants | ||
| Incidence of IDR | Clopidogrel | 24 | participants | ||
| Incidence of Stent Thrombosis | Cangrelor | 5 | participants | ||
| Incidence of Stent Thrombosis | Clopidogrel | 16 | participants | ||
| Incidence of Stroke | Cangrelor | 7 | participants | ||
| Incidence of Stroke | Clopidogrel | 5 | participants | ||
| Incidence of All-cause Mortality | Cangrelor | 94 | participants | ||
| Incidence of All-cause Mortality | Clopidogrel | 113 | participants | ||
Incidence of Procedure Events [Abrupt Closure, Threatened Abrupt Closure, Need for Urgent Coronary Artery Bypass Graft (CABG) Surgery, Unsuccessful Procedure, New Thrombus or Suspected Thrombus, and/or Acute Stent Thrombosis] | Cangrelor | 122 | participants | ||
Incidence of Procedure Events [Abrupt Closure, Threatened Abrupt Closure, Need for Urgent Coronary Artery Bypass Graft (CABG) Surgery, Unsuccessful Procedure, New Thrombus or Suspected Thrombus, and/or Acute Stent Thrombosis] | Clopidogrel | 142 | participants | ||
| Incidence of GUSTO Severe / Life-threatening | Cangrelor | 9 | participants | ||
| Incidence of GUSTO Severe / Life-threatening | Clopidogrel | 6 | participants |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00385138/results